Literature DB >> 32416772

Reviving the US CDC.

.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32416772      PMCID: PMC7255307          DOI: 10.1016/S0140-6736(20)31140-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
The COVID-19 pandemic continues to worsen in the USA with 1·3 million cases and an estimated death toll of 80 684 as of May 12. States that were initially the hardest hit, such as New York and New Jersey, have decelerated the rate of infections and deaths after the implementation of 2 months of lockdown. However, the emergence of new outbreaks in Minnesota, where the stay-at-home order is set to lift in mid-May, and Iowa, which did not enact any restrictions on movement or commerce, has prompted pointed new questions about the inconsistent and incoherent national response to the COVID-19 crisis. The US Centers for Disease Control and Prevention (CDC), the flagship agency for the nation's public health, has seen its role minimised and become an ineffective and nominal adviser in the response to contain the spread of the virus. The strained relationship between the CDC and the federal government was further laid bare when, according to The Washington Post, Deborah Birx, the head of the US COVID-19 Task Force and a former director of the CDC's Global HIV/AIDS Division, cast doubt on the CDC's COVID-19 mortality and case data by reportedly saying: “There is nothing from the CDC that I can trust”. This is an unhelpful statement, but also a shocking indictment of an agency that was once regarded as the gold standard for global disease detection and control. How did an agency that was the first point of contact for many national health authorities facing a public health threat become so ill-prepared to protect the public's health? In the decades following its founding in 1946, the CDC became a national pillar of public health and globally respected. It trained cadres of applied epidemiologists to be deployed in the USA and abroad. CDC scientists have helped to discover new viruses and develop accurate tests for them. CDC support was instrumental in helping WHO to eradicate smallpox. However, funding to the CDC for a long time has been subject to conservative politics that have increasingly eroded the agency's ability to mount effective, evidence-based public health responses. In the 1980s, the Reagan administration resisted providing the sufficient budget that the CDC needed to fight the HIV/AIDS crisis. The George W Bush administration put restrictions on global and domestic HIV prevention and reproductive health programming. The Trump administration further chipped away at the CDC's capacity to combat infectious diseases. CDC staff in China were cut back with the last remaining CDC officer recalled home from the China CDC in July, 2019, leaving an intelligence vacuum when COVID-19 began to emerge. In a press conference on Feb 25, Nancy Messonnier, director of the CDC's National Center for Immunization and Respiratory Diseases, warned US citizens to prepare for major disruptions to movement and everyday life. Messonnier subsequently no longer appeared at White House briefings on COVID-19. More recently, the Trump administration has questioned guidelines that the CDC has provided. These actions have undermined the CDC's leadership and its work during the COVID-19 pandemic. There is no doubt that the CDC has made mistakes, especially on testing in the early stages of the pandemic. The agency was so convinced that it had contained the virus that it retained control of all diagnostic testing for severe acute respiratory syndrome coronavirus 2, but this was followed by the admission on Feb 12 that the CDC had developed faulty test kits. The USA is still nowhere near able to provide the basic surveillance or laboratory testing infrastructure needed to combat the COVID-19 pandemic. But punishing the agency by marginalising and hobbling it is not the solution. The Administration is obsessed with magic bullets—vaccines, new medicines, or a hope that the virus will simply disappear. But only a steadfast reliance on basic public health principles, like test, trace, and isolate, will see the emergency brought to an end, and this requires an effective national public health agency. The CDC needs a director who can provide leadership without the threat of being silenced and who has the technical capacity to lead today's complicated effort. The Trump administration's further erosion of the CDC will harm global cooperation in science and public health, as it is trying to do by defunding WHO. A strong CDC is needed to respond to public health threats, both domestic and international, and to help prevent the next inevitable pandemic. Americans must put a president in the White House come January, 2021, who will understand that public health should not be guided by partisan politics. For more on how the CDC's advice has been questioned see https://apnews.com/7a00d5fba3249e573d2ead4bd323a4d4
  11 in total

1.  Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study.

Authors:  Yin Wu; Linda Kwakkenbos; Richard S Henry; Marie-Eve Carrier; Maria Gagarine; Sami Harb; Angelica Bourgeault; Lydia Tao; Andrea Carboni-Jiménez; Zelalem Negeri; Scott Patten; Susan J Bartlett; Luc Mouthon; John Varga; Andrea Benedetti; Brett D Thombs
Journal:  J Psychosom Res       Date:  2020-11-25       Impact factor: 3.006

2.  Why Contact Tracing Efforts Have Failed to Curb Coronavirus Disease 2019 (COVID-19) Transmission in Much of the United States.

Authors:  Eva Clark; Elizabeth Y Chiao; E Susan Amirian
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

3.  Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

Authors:  Brett D Thombs; Linda Kwakkenbos; Richard S Henry; Marie-Eve Carrier; Scott Patten; Sami Harb; Angelica Bourgeault; Lydia Tao; Susan J Bartlett; Luc Mouthon; John Varga; Andrea Benedetti
Journal:  J Psychosom Res       Date:  2020-10-03       Impact factor: 3.006

4.  How big is your bubble? Characteristics of self-isolating household units ('bubbles') during the COVID-19 Alert Level 4 period in New Zealand: a cross-sectional survey.

Authors:  Nethmi Kearns; Nick Shortt; Ciléin Kearns; Allie Eathorne; Mark Holliday; Diane Mackle; John Martindale; Alex Semprini; Mark Weatherall; Richard Beasley; Irene Braithwaite
Journal:  BMJ Open       Date:  2021-01-28       Impact factor: 2.692

5.  The Tragedy of Liberal Democratic Governance in the Face of Global Threats.

Authors:  Eric Muraille; Philippe Naccache; Julien Pillot
Journal:  Front Public Health       Date:  2022-07-08

6.  COVID-19: test, trace and isolate-new epidemiological data.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2020-06-27       Impact factor: 5.476

7.  Public Health Strategies Contain and Mitigate COVID-19: A Tale of Two Democracies.

Authors:  Joshua J Solano; Dennis G Maki; Terry A Adirim; Richard D Shih; Charles H Hennekens
Journal:  Am J Med       Date:  2020-08-15       Impact factor: 4.965

8.  Racial and Ethnic Disparities in COVID-19 Outcomes: Social Determination of Health.

Authors:  Samuel Raine; Amy Liu; Joel Mintz; Waseem Wahood; Kyle Huntley; Farzanna Haffizulla
Journal:  Int J Environ Res Public Health       Date:  2020-11-03       Impact factor: 3.390

9.  In the 2020 US election, we can choose a just future.

Authors:  Rhea W Boyd; Nancy Krieger; Camara Phyllis Jones
Journal:  Lancet       Date:  2020-10-19       Impact factor: 79.321

10.  FDA review times for new drugs in ophthalmology.

Authors:  Michelle A Carpenter; Gary D Novack
Journal:  Ocul Surf       Date:  2020-08-11       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.